EUVIMEDEUVIMED entdecken
LeitlinieOpen Access

Levels of evidence and grades of recommendation supporting European society for medical oncology clinical practice guidelines

Marko Skelin, Bruna Perkov-Stipičin, Sanja Vušković, Marina Šandrk Plehaček, Ane Bašić, David Šarčević, Maja Ilić, Ivan Krečak

Oncology Research · 2024

DOI: 10.32604/or.2024.048948 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Oncology Research, 2024. Verfasst von Marko Skelin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy Department, General Hospital of Šibenik-Knin County, Šibenik, Croatia. Hauptthemen laut MEDLINE: Practice Guidelines as Topic, Medical Oncology, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The European Society for Medical Oncology (ESMO) guidelines are among the most comprehensive and widely used clinical practice guidelines (CPGs) globally. However, the level of scientific evidence supporting ESMO CPG recommendations has not been systematically investigated. This study assessed ESMO CPG levels of evidence (LOE) and grades of recommendations (GOR), as well as their trends over time across various cancer settings.

Methods

We manually extracted every recommendation with the Infectious Diseases Society of America (IDSA) classification from each CPG. We examined the distribution of LOE and GOR in all available ESMO CPG guidelines across different topics and cancer types.

Results

Among the 1,823 recommendations in the current CPG, 30% were classified as LOE I, and 43% were classified as GOR A. Overall, there was a slight decrease in LOE I (-2%) and an increase in the proportion of GOR A (+1%) in the current CPG compared to previous versions. The proportion of GOR A recommendations based on higher levels of evidence such as randomized trials (LOE I-II) shows a decrease (71% vs. 63%, p = 0.009) while recommendations based on lower levels of evidence (LOE III-V) show an increase (29% vs. 37%, p = 0.01) between previous and current version. In the current versions, the highest proportion of LOE I (42%) was found in recommendations related to pharmacotherapy, while the highest proportion of GOR A recommendations was found in the areas of pathology (50%) and diagnostic (50%) recommendations. Significant variability in LOE I and GOR A recommendations and their changes over time was observed across different cancer types.

Conclusion

One-third of the current ESMO CPG recommendations are supported by the highest level of evidence. More well-designed randomized clinical trials are needed to increase the proportion of LOE I and GOR A recommendations, ultimately leading to improved outcomes for cancer patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Practice Guidelines as TopicMedical OncologyNeoplasmsHumansEuropeEvidence-Based MedicineSocieties, Medical

Stichwörter der Autor:innen

Clinical practice guidelinesESMO guidelinesGrade of recommendationLevel of evidence

Autor:innen und Institutionen

  • Pharmacy Department, General Hospital of Šibenik-Knin County, Šibenik, Croatia.
  • Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
  • Undergraduate Study in Nursing, University of Applied Sciences, Šibenik, Croatia.
  • Department of Oncology, University Hospital Center Zagreb, Zagreb, Croatia.
  • Pharmacies Joukhadar, Sveta Nedelja, Croatia.
  • Pharmacies Prima Pharme, Zagreb, Croatia.

Zitieren

APA

Skelin, M., Perkov-Stipičin, B., Vušković, S., Šandrk Plehaček, M., Bašić, A., Šarčević, D., Ilić, M., & Krečak, I. (2024). Levels of evidence and grades of recommendation supporting European society for medical oncology clinical practice guidelines. Oncology Research. https://doi.org/10.32604/or.2024.048948

Vancouver

Skelin M, Perkov-Stipičin B, Vušković S, Šandrk Plehaček M, Bašić A, Šarčević D, et al. Levels of evidence and grades of recommendation supporting European society for medical oncology clinical practice guidelines. Oncology Research. 2024. doi:10.32604/or.2024.048948

BibTeX
@article{Skelin2024,
  author = {Skelin, Marko and Perkov-Stipičin, Bruna and Vušković, Sanja and Šandrk Plehaček, Marina and Bašić, Ane and Šarčević, David and Ilić, Maja and Krečak, Ivan},
  title = {Levels of evidence and grades of recommendation supporting European society for medical oncology clinical practice guidelines},
  journal = {Oncology Research},
  year = {2024},
  doi = {10.32604/or.2024.048948}
}
Kostenlos starten →